The global impact of Indian generics on access to health.

Over the last decades, most countries have indeed acceded to at least one global or regional covenant confirming the right to health (1). The right to health should be achieved, among others, by making essential medicines of assured quality at an affordable price (2). but in this respect, a significant gap exists today between the majority of high-income countries, where the state has sufficient resources to ensure access to quality medicines to people in its territory; and many lowand middleincome countries, where the state lacks the capacity to do so. Despite the availability of centres of excellence for several major diseases, and adequate treatment options, the lack of global equity in health and in access to healthcare and good quality medicines can be regarded as one of the chief human rights dilemmas in the 21 century (3).